Leakage decrease detected by dynamic susceptibility-weighted contrast-enhanced perfusion MRI predicts survival in recurrent glioblastoma treated with bevacizumab
Crossref DOI link: https://doi.org/10.1007/s12094-016-1502-4
Published Online: 2016-03-30
Published Print: 2017-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hilario, A. http://orcid.org/0000-0001-5143-603X
Sepulveda, J. M.
Hernandez-Lain, A.
Salvador, E.
Koren, L.
Manneh, R.
Ruano, Y.
Perez-Nuñez, A.
Lagares, A.
Ramos, A.
Text and Data Mining valid from 2016-03-30